We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
A resource to help commissioners provide cost-effective interventions to prevent cardiovascular disease.
A professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol
These reports assess cardiovascular disease in the south-west, focusing on risk factors, heart disease, stroke, kidney disease and diabetes.
Sets out Public Health England's (PHE) initiatives for cardiovascular disease (CVD) prevention.
A study was performed among the type 2 diabetes patients attending M.V. Hospital for Diabetes in Chennai
An exploratory study from Zhejiang, China
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.
Hypertension and diabetes are major risk factors for cardiovascular disease (CVD)
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
Digital NHS Health Check to be rolled out across England next spring delivering an additional one million checks in the first 4 years.
This policy brief shares findings from a pragmatic, cluster randomised controlled trial in Zhejiang province, China
This publication brings together Public Health England's (PHE’s) broad-ranging work in addressing cardiovascular disease.
Cardiovascular disease (CVD) is a major cause of death in China
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in clinical commissioning groups (CCG) areas.
Evidence and guidance to help healthcare professionals to prevent heart attacks, strokes and dementia and to improve cardiovascular health.
Current cardiovascular disease (CVD) prevention is based on diagnosis and treatment of specific disease
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.